People: Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,173.50INR
30 Jul 2014
Price Change (% chg)

Rs54.85 (+4.90%)
Prev Close
Rs1,118.65
Open
Rs1,128.40
Day's High
Rs1,192.45
Day's Low
Rs1,112.60
Volume
2,127,298
Avg. Vol
546,680
52-wk High
Rs1,192.45
52-wk Low
Rs742.55

Search Stocks

Summary

Name Age Since Current Position

Desh Gupta

Executive Chairman of the Board

Nilesh Gupta

2013 Group President, Managing Director, Executive Director

Vinita Gupta

2013 Chief Executive Officer, Director

Kamal Sharma

2013 Executive Vice Chairman of the Board

Shakti Chakraborty

Group President - India Region Formulations & CIS

Vinod Dhawan

President - AAMLA and Business Development

Alok Ghosh

2010 President - Technical Operations

Naresh Gupta

President - API & Global TB

Rajender Kamboj

President - Novel Drug Discovery & Development

Cyrus Karkaria

2010 President - Biotechnology

Divakar Kaza

2008 President - Human Resources

Paul McGarty

President of Lupin Pharmaceuticals Inc., USA

Sofia Mumtaz

2013 President - IPMG

Ramesh Swaminathan

2007 President - Finance & Planning

Sunil Makharia

Executive Vice President - Finance

R. Raghav

2011 Executive Vice President - Marketing & Sales

Dhananjay Bakhle

Executive Vice President - Medical Research

Debabrata Chakravorty

Executive Vice President - Supply Planning & Strategic Sourcing

Rajendra Chunodkar

2011 Executive Vice President - Technical

Ganadish Kamath

Executive Vice President - Corporate Quality Assurance

Vilas Satpute

Executive Vice President - API Manufacturing

Rajvardhan Satam

2008 Compliance Officer, Company Secretary

M. Gupta

2011 Executive Director

Dileep Choksi

64 2012 Non-Executive Independent Director

Vijay Kelkar

72 2010 Non-Executive Independent Director

K. Mada

79 Non-Executive Independent Director

R. Shah

82 2005 Non-Executive Independent Director

Richard Zahn

2010 Non-Executive Independent Director

Rajiv Pillai

IR Contact Officer

Biographies

Name Description

Desh Gupta

Dr. Desh Bandhu Gupta is Executive Chairman of the Board of Lupin Limited. He is an honorary doctor of philosophy with a master's degree in chemistry, Dr. Gupta started his career teaching chemistry at Birla Institute of Science and Technology, Pilani, Rajashthan. Since 1968, when he founded the company, Dr. Gupta has steered Lupin towards the forefront of India pharmaceuticals. In recent years, he has spearheaded the restructuring of Lupin's operations, and the research and innovation programs in new drug research and novel drug delivery systems.

Nilesh Gupta

Mr. Nilesh Gupta is Group President, Managing Director, Executive Director of Lupin Ltd. He has been appointed as Managing Director of the Company effective September 1, 2013. He is is a chemical engineer from UDCT, Mumbai and a graduate with honours from the Wharton School, USA specializing in healthcare, strategic management and finance. His diverse portfolio includes Intellectual Property, Strategy & Management, Research & Development, Projects, Manufacturing, QA and Supply Chain Management. Mr. Gupta has demonstrated exemplary performance in integrating and this diversified portfolio and ably contributing to the growth and profitability of the Advanced markets (US & EU) in particular and the Company in general. He directed the IP strategy of the Company towards achieving niche position for the chosen products which enabled the Company achieve sustainable revenue/profit. Under his leadership, the team ensured flawless and immaculately timed launches of several products in the international market. He is a sound business leader and team builder.

Vinita Gupta

Ms. Vinita Gupta is Chief Executive Officer, Director of Lupin Limited. She has been appointed as Chief Executive Officer of the Company effective September1, 2013. She has an M.B.A. from the J. L. Kellogg Graduate School of Management, USA and a pharmacy graduate from the University of Mumbai, was responsible for developing the Company’s entry strategy into North America and Europe. Ms. Vinita has been responsible for establishing the Company’s presence in the US, the market of the Company and Europe by forging alliances with several marketing and distribution partners. She has established the Company’s brand and generic business in the US and also oversees the Company’s US FDA filings. Ms. Vinita is presently designated Group President & Chief Executive Officer of Lupin Pharmaceuticals, Inc., USA, (LPI) a wholly-owned subsidiary of the Company. Today, LPI is a specialty pharmaceutical company in the US with a growing presence in the branded as well as generic pharmaceutical industry.

Kamal Sharma

Dr. Kamal K. Sharma, Ph.D., has been appointed as Executive Vice Chairman of the Board of Lupin Limited effective September 1, 2013. Dr. Kamal K. Sharma is a chemical engineer from the Indian Institute of Technology (lIT), Kanpur with a postgraduate diploma in industrial management from the Jamnalal Bajaj Institute of Management Studies, Mumbai and a Ph.D. in Economics from lIT, Mumbai. He has also completed an advanced management programme from Harvard Business School, Boston. Dr. Sharma has industry experience spanning over three decades and has held several senior management positions in the fields of projects, operations, corporate development and general management in pharma and chemical industries. His other directorships are Kyowa Pharmaceutical Industry Co., Ltd., Japan; Generic Health Pty Ltd., Australia; Pharma Dynamics (Proprietary) Ltd., South Africa; pin Healthcare Ltd.; Faisa Financial Pvt. Ltd; Templetree Properties Pvt. Ltd.

Shakti Chakraborty

Mr. Shakti Chakraborty is Group President - India Region Formulations & CIS of Lupin Limited. He is a graduate in commerce and heads the India region business for finished products and has driven Lupin's entry in the lifestyle segment.

Vinod Dhawan

Alok Ghosh

Naresh Gupta

Rajender Kamboj

Cyrus Karkaria

Divakar Kaza

Paul McGarty

Sofia Mumtaz

Ramesh Swaminathan

Mr. Ramesh Swaminathan is President - Finance & Planning of Lupin Limited. He is a Chartered Accountant with over two decades experience, Mr. Swaminathan leads the Finance and Planning function. Prior to joining Lupin Mr. Swaminathan was with Henkel, Germany where he held corporate responsibilities as Regional Financial Controller for several countries across Central and Eastern Europe and the Middle East. Prior to that assignment, he was the CFO of Henkel India. He has also worked with companies such as VST Industries, the SPIC group and Standard Chartered Bank. Mr. Swaminathan is a member of the Institute of Chartered Management Accountants, UK and the Institute of Company Secretaries in India.

Sunil Makharia

R. Raghav

Dhananjay Bakhle

Debabrata Chakravorty

Rajendra Chunodkar

Ganadish Kamath

Vilas Satpute

Rajvardhan Satam

M. Gupta

Dileep Choksi

Shri. Dileep C. Choksi is Non-Executive Independent Director of Lupin Ltd., since October 23, 2012. He is a Chartered Accountant, qualified lawyer and a Cost Accountant with over 35 years of experience. His areas of specialisation include tax planning and structuring for domestic and international clients, including expatriates, finalising collaborations and joint ventures, executive advisory and decision support, corporate restructuring with a focus on startups, turnaround and change management strategies and analysing tax impact of various instruments. Mr. Choksi advises some of India’s business houses on various strategic matters and multinational clients on cross border structuring. Mr. Choksi was the former Joint Managing Partner of Deloitte in India. He has set up C. C. Chokshi Advisors Pvt. Ltd., the activities of which aim to provide complete solutions for all business requirements.

Vijay Kelkar

Dr. Vijay Laxman Kelkar, Ph.D., is Non-Executive Independent Director of Lupin Ltd. Dr. Vijay Kelkar holds Ph.D, from the University of California at Berkeley, M.S. from the University of Minnesota and B.S. from Pune University. He held senior positions in the Government of India and was Chairman/ Member of several high-powered committees, councils, task forces, working groups, set up by different ministries and departments of the Government of India. Dr. Kelkar had delivered lectures at the Universities of California, Pennsylvania, Vanderbilt, Harvard and Cornell in the U.S and was visiting Professor at the South Asia Institute, Heidelberg University, West Germany and Center for Economic Development and Administration, Government of Nepal. He was a senior faculty member of the Administrative Staff College of India, Hyderabad and Instructor - Microeconomics, University of California, U.S.A. Dr. Kelkar has authored many books, publications and journals on micro and macro economics, reforms of union public sector, emerging challenges and on trade policies. In 2011, Dr. Kelkar was conferred ‘Padma Vibhushan’ for his distinguished and exemplary service to the nation.

K. Mada

Dr. K. U. Mada is Non-Executive Independent Director of Lupin Limited. He is an eminent economist and development banker. He holds a Ph.D. degree in Economics from the University of Mumbai. Dr. Mada has also received a certificate in financial management from the Jamnalal Bajaj Institute of Management Studies, Mumbai. He taught Economics at Jai Hind College, Mumbai, for six years before joining the Reserve Bank of India in 1965. Later on he moved to the Industrial Development Bank of India (IDBI) where he worked in several senior capacities, including as Executive Director for over three years. He was Chairman/Member of a number of committees constituted by lDBI/other financial institutions and Government of India. Dr. Mada has written books, including ‘A Journey Through Development Banking (2005)’ and also published articles in well-known journals. Dr. Mada represented lDBI as Speaker/participant at several national and international conferences/ seminars on economic, corporate and institutional affairs. He was also a visiting faculty at management institutes. He was on the Board of Governance of the Management Development Institute, Gurgaon, for ten years.

R. Shah

Mr. R. A. Shah is Non-Executive Independent Director of Lupin Limited. He is a senior partner of Crawford BayLey & Company, a firm of SoLicitors and Advocates in Mumbai. He is on the boards of severaL reputed companies. Mr. Shah is a member of the Managing Committee of Bombay Chamber of Commerce and Indo German Chamber of Commerce. He is also a Member of the Committee for Revision of SEBI Takeover Code and President of Society of Indian Law Firms (Western Region).

Richard Zahn

Mr. Richard A. Zahn is Non-Executive Independent Director of Lupin Limited. Mr. Richard holds B. S. (Business Administration) with Honors, Kansas StateTeachers College, Kansas. He had completed Executive Education with Amos Tuck School, Dartmouth University, Harvard/MIT Program on Negotiation, The Wharton School, University of Pennsylvania and National Association of Corporate Directors -Certificate of Director Education. Mr. Richard is the Managing Partner of HMJ Global Partners, a corporate governance and not-for-profit public policy advisory group. With more than 30 years of experience in the biotechnology and pharmaceutical industries, he is an established leader and strategist in healthcare research and development, marketing management, managed care, and human resources. Mr. Richard was President of Schering Laboratories, U.S., Director, Schering Corporation and Corporate Vice President of Schering-Plough Corporation, a global research-based company engaged in the discovery,development, manufacturing and marketing of pharmaceutical, biotechnology and healthcare prescription pharmaceutical marketing arm for Schering-Plough. Mr. Richard spent 20 years at Johnson & Johnson. Mr. Richard has focused his efforts on world economic development and public policy. He has received several awards for his work towards various organizations and charities with particular focuson healthcare and minority issues.

Rajiv Pillai

Search Stocks